rapid
progress
improv
molecular
technolog
allow
research
switch
tradit
approach
viru
detect
clinic
sampl
multiplex
simultan
detect
multipl
pathogen
singl
assay
number
differ
pcr
base
assay
detect
discoveri
multipl
pathogen
develop
detect
microarray
proven
use
identif
discoveri
virus
homolog
known
speci
use
guid
select
sampl
analysi
sequenc
howev
microarray
base
nucleic
acid
hybrid
complex
design
perform
routin
donor
test
exhibit
compar
low
sensit
detect
usual
around
genom
copi
target
viru
per
analyz
sampl
sever
pcr
base
assay
coupl
oligonucleotid
microarray
technolog
call
resequenc
array
design
allow
simultan
detect
genotyp
target
group
virus
critic
bloodborn
pathogen
virus
respiratori
virus
virus
respiratori
adenovirus
differ
serotyp
pcr
base
approach
allow
increas
sensit
detect
copi
target
rna
dna
sampl
pcr
multiplex
highli
use
volum
sampl
time
test
critic
donor
elig
de
test
tissu
organ
transplant
current
regul
requir
de
test
perform
use
assay
approv
licens
us
food
drug
administr
fda
howev
autom
assay
system
design
screen
larg
number
sampl
without
strict
limit
sampl
volum
may
complet
suitabl
ideal
need
de
test
tissu
organ
transplant
main
goal
studi
present
evalu
feasibl
develop
sensit
specif
assay
rapid
detect
identif
group
target
viral
pathogen
follow
viral
pathogen
includ
array
human
immunodefici
viru
type
human
tcell
leukemia
hepat
c
viru
hcv
west
nile
viru
wnv
singlestrand
rna
genom
vaccinia
viru
vacv
hepat
b
viru
hbv
doublestrand
dna
genom
hbv
also
singlestrand
rna
stage
list
virus
includ
requir
de
test
tissu
transplant
besid
histor
target
virus
found
allografttransmit
recipi
present
studi
realtim
pcr
array
sybrgreen
chemistri
target
eight
viral
pathogen
list
develop
evalu
analyt
clinic
panel
array
demonstr
accept
perform
test
analyt
panel
donor
clinic
sampl
research
studi
conduct
fda
use
previous
frozen
blood
sampl
review
depart
health
human
servic
food
drug
administr
research
involv
human
subject
committe
rishc
protocol
entitl
detect
infecti
agent
previous
frozen
blood
sampl
patient
variou
ill
healthi
blood
donor
clinic
plasma
sampl
posit
hbv
hcv
use
studi
exist
clinic
diagnost
sampl
kept
nih
blood
bank
inform
left
sampl
record
manner
subject
identifi
directli
identifi
written
inform
consent
particip
waiv
cfr
b
six
plasma
sampl
posit
estim
contain
genom
copi
number
per
ml
six
plasma
sampl
posit
hcv
estim
contain
genom
copi
numberml
five
plasma
sampl
posit
hbv
estim
contain
copi
numberml
copi
number
virus
sampl
provid
nih
blood
bank
inform
subtyp
genotyp
virus
avail
amount
clinic
sampl
suffici
test
pcr
array
studi
posit
pcr
product
obtain
test
use
pcr
array
confirm
valid
sequenc
facil
biotechnolog
resourc
fdacber
use
insignia
program
http
insigniacbcbumdeduqueryphp
bioinformat
line
tool
develop
center
bioinformat
comput
biolog
univers
maryland
choos
specif
dna
rna
signatur
sequenc
custom
length
gc
content
target
virus
compar
sequenc
analysi
complet
genom
perform
use
mvista
http
genomelblgovvistamvistasubmitshtml
multipl
nucleotid
sequenc
align
nsa
creat
visual
conserv
genom
area
use
http
wwwmegasoftwarenet
specif
criteria
primer
amplicon
select
sybr
green
base
pcr
array
rang
anneal
temperatur
primer
high
gc
content
primer
allow
higher
specif
anneal
amplicon
size
rang
bp
order
high
pcr
amplif
effici
suffici
distinguish
product
primer
dimer
base
melt
peak
tm
primer
check
potenti
dimer
format
use
primer
express
softwar
version
appli
biosystem
design
primer
check
use
nation
center
biotechnolog
inform
ncbi
basic
local
align
search
tool
blast
http
blastncbinlmnihgovblastcgi
avoid
crossreact
speci
newli
design
previous
publish
primer
set
adapt
final
version
realtim
pcr
array
list
tabl
addit
primer
specif
human
betaglobin
gene
includ
array
intern
control
qualiti
dnarna
prepar
well
estim
viral
copi
number
per
host
cell
need
last
row
tabl
total
cellular
dna
chronic
infect
cell
cultur
vacv
viral
genom
cdna
copi
spike
human
dna
hcv
wnv
dna
isol
human
plasma
infect
individu
hbv
use
posit
templat
initi
test
list
last
column
tabl
dna
rna
panel
creat
clone
specif
synthet
templat
viru
pgemteasi
vector
promega
ta
clone
follow
vitro
transcript
obtain
rna
standard
hcv
wnv
creat
plasmid
list
tabl
nucleotid
number
tabl
refer
locat
partial
viral
genom
clone
pgemteasi
vector
accord
follow
complet
genom
sequenc
avail
genbank
hbv
hcv
vacv
wnv
establish
realtim
pcr
standard
curv
copi
number
calcul
plasmid
carri
one
copi
specif
viral
gene
size
plasmid
x
bp
use
determin
molecular
weight
dalton
gmol
w
gmol
x
bp
da
copi
number
target
viral
gene
determin
plasmid
concentr
cdna
molecular
weight
plasmid
molecul
copi
number
cdna
avogadro
number
w
know
number
plasmid
molecul
target
viral
gene
seri
dilut
made
gener
pcr
standard
curv
develop
analyt
standard
use
calcul
intra
interassay
reproduc
quantif
virusspecif
primer
set
mean
c
valu
standard
deviat
sd
coeffici
variat
cv
calcul
data
obtain
three
replic
standard
dilut
intraassay
reproduc
three
realtim
pcr
assay
consist
three
replic
nine
total
interassay
reproduc
cv
calcul
sdmean
c
ml
human
plasma
use
total
viral
rnadna
extract
use
qiaamp
viral
rna
minikit
qiagen
trna
sigma
use
carrier
rna
prepar
final
elut
step
rnadna
buffer
ave
precipit
ethanol
mm
nacl
overnight
rnadna
pellet
wash
ethanol
dissolv
depctreat
water
immedi
use
cdna
synthesi
superscript
ii
rt
invitrogen
random
hexam
invitrogen
total
reaction
volum
volum
cdnadna
sampl
adjust
depctreat
water
whole
volum
per
primer
set
immedi
use
pcr
array
test
pcr
perform
use
biorad
realtim
system
power
sybr
green
pcr
master
mix
appli
biosystem
one
reaction
total
contain
pcr
master
mix
primer
dnacdna
templat
singl
viru
test
section
result
use
dnacdna
templat
sampl
cdna
synthesi
univers
pcr
condit
primer
set
includ
array
min
one
cycl
cycl
denatur
anneal
extens
min
follow
melt
curv
read
increment
realtim
pcr
data
download
plate
format
biorad
cfx
manag
ms
excel
analyz
manual
two
type
sampl
serv
background
control
determin
c
cut
type
neg
control
ng
human
cellular
dna
type
neg
control
neg
donor
plasma
data
collect
separ
experi
human
cellular
dna
control
neg
donor
plasma
standard
c
cut
primer
threshold
set
pcr
machin
default
set
base
fals
posit
rate
less
follow
method
use
estim
c
cut
rang
c
obtain
neg
sampl
primer
set
array
c
cut
calcul
rang
n
type
neg
control
data
c
c
cut
calcul
rang
n
type
neg
control
data
c
even
overlap
c
measur
truli
posit
truli
neg
sampl
detect
pcr
array
data
tm
paramet
use
defin
obtain
pcr
product
specif
comparison
expect
tm
peak
rang
analyt
sensit
primer
set
determin
singl
viru
test
use
fdacber
panel
kindli
provid
dr
stephen
kerbi
fdacber
consist
variou
amount
virus
genom
copiesml
spike
normal
human
plasma
panel
follow
virus
use
test
three
differ
panel
hbv
base
genotyp
hcv
genotyp
wnv
base
strain
panel
use
test
commerci
licens
nat
assay
develop
describ
previous
three
separ
rna
panel
use
test
first
consist
variou
amount
group
subtyp
b
isol
copiesml
second
consist
sampl
repres
variou
concentr
group
n
group
subtyp
c
e
f
g
copiesml
viru
third
panel
consist
circul
recombin
form
crf
ae
ag
copiesml
crf
divers
panel
develop
southern
research
institut
frederick
md
consist
differ
clinic
isol
twentyeight
differ
isol
three
subtyp
g
group
three
group
one
group
n
three
differ
isol
includ
panel
isol
obtain
nih
aid
research
refer
reagent
program
arrrp
divis
aid
niaid
nih
follow
catalog
number
group
envelop
subtyp
appropri
indic
parenthes
isol
c
ea
e
f
f
f
unaid
network
hiv
isol
character
isol
jrcsf
b
dr
irvin
chen
isol
b
multicent
aid
cohort
studi
isol
b
dr
neal
halsey
isol
c
dr
robert
bolling
isol
c
dr
paolo
miotti
dr
victoria
poloni
isol
e
dr
kenrad
isol
g
g
dr
alash
le
abimiku
isol
g
dr
bobkov
dr
jonathon
weber
isol
n
dr
sentob
saragosti
simon
isol
dr
robin
weiss
isol
dr
stefan
wiktor
dr
mark
rayfield
isol
dr
lutz
dr
friedrich
deinhardt
group
subtyp
base
design
report
nih
arrrp
low
passag
viru
stock
prepar
median
tissu
cultur
infect
dose
ml
viru
contain
supernat
determin
fresh
human
pbmc
isol
previous
describ
infecti
unit
iu
viru
stock
titrat
isol
number
iu
use
viral
rna
isol
pcr
calcul
base
dilut
factor
rang
per
pcr
reaction
pcr
approach
base
sybr
green
chemistri
allow
simultan
detect
multipl
target
chosen
appli
array
perform
virusspecif
primer
set
target
least
three
differ
genom
site
viral
pathogen
design
realtim
pcr
array
use
insignia
program
bioinformat
tool
help
choos
specif
dna
rna
signatur
differ
bacteria
viral
pathogen
includ
prebuilt
insignia
databas
sequenc
highli
conserv
region
code
viral
polymeras
structur
protein
select
design
candid
primer
addit
perform
nucleotid
sequenc
align
nsa
complet
viral
genom
conserv
genom
area
differ
subtypesgenotyp
differ
isol
target
virus
previous
publish
primer
design
pcr
detect
target
virus
also
adapt
evalu
overal
total
primer
initi
design
use
specif
criteria
current
realtim
pcr
array
see
materi
method
cover
eight
target
virus
hbv
hcv
htlv
wnv
vacv
primer
design
test
effect
specif
amplifi
respect
target
uniform
pcr
condit
use
anneal
temperatur
primer
candid
primer
pair
first
test
specif
sensit
pcr
amplif
assess
realtim
pcr
crosstest
human
pbmc
dna
ngpcr
reaction
healthi
donor
dna
human
cell
cultur
infect
variou
target
virus
human
dna
spike
known
amount
genom
copi
variou
virus
import
ensur
select
primer
target
specif
viru
would
nonspecif
amplifi
dna
sampl
melt
temperatur
tm
peak
product
amplifi
target
viru
clearli
differenti
tm
peak
primer
dimer
nonspecif
product
produc
pcr
dna
rna
panel
creat
clone
synthet
templat
list
tabl
spike
genom
copi
viru
ng
human
background
dna
sensit
candid
primer
set
target
viru
assess
use
panel
exampl
experiment
test
specif
primer
set
target
gag
gene
sensit
dna
analyt
standard
shown
figur
serial
dilut
plasmid
dna
correspond
genom
copi
spike
ng
normal
human
dna
infect
cell
posit
control
dna
uninfect
human
pbmc
neg
control
dna
use
experi
singl
melt
peak
tm
correspond
specif
product
observ
unspecif
amplif
regist
figur
reveal
standard
curv
show
correl
copi
number
target
gene
ct
valu
slope
limit
sensit
determin
assay
viral
genom
copiespcr
evalu
total
primer
pair
target
eight
differ
virus
chosen
realtim
pcr
array
base
specif
sensit
tabl
among
five
primer
set
previous
publish
primer
set
origin
design
current
studi
tabl
show
sequenc
previous
publish
primer
set
select
realtim
pcr
array
refer
origin
sourc
analyt
sensit
express
genom
copypcr
primer
set
tabl
estim
use
dnarna
analyt
panel
describ
coverag
variant
ie
differ
subtyp
genotyp
viru
tabl
estim
use
nsa
degen
nucleotid
introduc
primer
set
base
nsa
perform
inhous
obtain
broader
coverag
tm
peak
rang
product
state
tabl
primer
set
establish
test
select
primer
analyt
clinic
panel
addit
intra
interassay
reproduc
quantif
primer
set
evalu
use
three
replic
standard
dilut
dna
rna
analyt
standard
three
realtim
pcr
assay
run
coeffici
variat
cv
c
valu
intra
interassay
respect
data
depict
mean
c
standard
deviat
sd
cv
primer
set
select
realtim
pcr
array
standard
concentr
shown
tabl
evalu
sensit
select
primer
use
fdacber
panel
kindli
provid
dr
stephen
kerbi
fda
consist
variou
amount
virus
spike
normal
human
plasma
specif
develop
use
evalu
commerci
licens
nat
assay
tabl
summar
test
result
select
primer
target
virus
one
four
primer
set
target
could
detect
subtyp
b
rna
concentr
copiesml
human
plasma
two
specif
primer
set
detect
rna
copiesml
plasma
primer
set
target
conserv
pol
region
contain
degen
nucleotid
support
broader
variant
coverag
could
detect
viru
viral
genom
copiesml
plasma
rna
detect
primer
set
concentr
copiesml
primer
set
concentr
copiesml
anoth
primer
set
detect
copiesml
hbv
genotyp
dna
detect
primer
set
copiesml
copiesml
third
hbv
specif
primer
set
detect
hbv
copiesml
plasma
hcv
specif
primer
set
target
viral
detect
hcv
rna
concentr
copiesml
plasma
two
wnvspecif
primer
set
target
e
protein
gene
target
detect
wnv
copiesml
third
primer
set
also
target
gave
posit
signal
copiesml
plasma
four
specif
primer
set
evalu
test
anoth
fdacber
analyt
panel
contain
broad
spectrum
subtyp
summar
tabl
subtyp
f
group
group
isol
panel
could
success
amplifi
four
select
primer
set
detect
limit
rna
copyml
plasma
subtyp
crf
group
group
n
isol
could
amplifi
least
one
four
primer
set
rna
copiesml
plasma
tabl
tm
peak
pcr
product
amplifi
differ
subtyp
vari
within
tabl
four
select
specif
primer
set
amplifi
subtyp
b
group
highest
sensit
copiesml
plasma
examin
specif
abil
array
detect
differ
isol
within
subtyp
differ
isol
array
addit
test
primer
anoth
panel
develop
southern
research
institut
panel
contain
three
differ
isol
subtyp
g
group
three
isol
group
one
isol
group
n
three
differ
isol
infecti
dose
hiv
isol
panel
determin
median
tissu
cultur
infect
dose
titrat
dose
viru
use
pcr
reaction
calcul
result
test
specif
primer
shown
figur
experi
evalu
coverag
variant
estim
rel
sensit
four
specif
primer
set
base
cycl
threshold
c
valu
obtain
isol
test
two
primer
set
target
conserv
pol
region
abl
detect
subtyp
high
sensit
c
one
primer
set
detect
group
n
isol
three
isol
group
ct
detect
crossreact
specif
primer
type
hiv
three
isol
studi
input
detect
specif
primer
set
low
ct
valu
data
shown
complet
sensit
test
primer
set
analyt
panel
final
expect
tm
peak
rang
amplicon
arrang
work
array
plate
format
figur
evalu
specif
possibl
crossreact
primer
array
genom
copi
viru
spike
ng
human
dna
use
posit
templat
amount
human
dna
use
neg
control
experi
array
test
target
virus
use
dna
standard
list
tabl
posit
templat
test
duplic
one
human
dna
neg
control
one
notempl
control
ntc
includ
everi
test
experi
definit
posit
signal
set
threshold
cycl
cutoff
c
see
materi
method
tm
peak
within
expect
rang
figur
crossreact
detect
primer
set
array
use
dna
standard
set
data
shown
seventeen
clinic
plasma
sampl
obtain
nih
blood
bank
donor
test
posit
hbv
hcv
use
evalu
array
sensit
specif
genom
copi
viru
virusposit
plasma
sampl
previous
determin
nih
blood
bank
use
commerci
assay
approv
donor
screen
repres
result
test
three
hbvposit
plasma
sampl
pt
use
array
shown
figur
threshold
cycl
cut
assay
perform
plasma
sampl
set
c
see
materi
method
well
c
lower
cutoff
obtain
tm
peak
within
expect
tm
rang
indic
posit
amplif
hbv
target
gene
highlight
blue
circl
figur
green
color
code
hbv
sampl
tm
peak
product
obtain
two
hbv
specif
primer
set
well
pt
well
within
expect
rang
c
valu
respect
sampl
three
hbv
specif
primer
set
gave
tm
peak
within
expect
rang
well
c
valu
rang
genom
copi
number
hbv
plasma
sampl
copiesml
correspond
copiespcr
well
white
color
code
red
circl
human
betaglobin
gene
specif
primer
set
serv
intern
control
produc
posit
signal
three
plasma
sampl
test
c
valu
well
figur
show
qualiti
rnadna
sampl
prepar
equal
good
plasma
three
patient
final
tm
rang
primer
set
adjust
test
clinic
panel
base
result
test
clinic
sampl
accord
nsa
perform
design
two
primer
set
target
gene
region
hbv
two
differ
tm
rang
depend
hbv
genotyp
figur
well
lower
tm
rang
detect
genotyp
higher
tm
rang
genotyp
b
c
differ
tm
rang
occur
due
singl
nucleotid
polymorph
snp
amplicon
sequenc
lead
differ
gc
nucleotid
content
product
tabl
summar
result
test
virusposit
clinic
sampl
use
develop
array
least
two
differ
specif
primer
set
could
detect
target
viru
case
one
except
one
posit
sampl
viral
genom
copi
per
pcr
reaction
amplifi
one
primer
set
posit
clinic
sampl
viral
genom
copiesml
plasma
copiespcr
reaction
detect
least
two
primer
set
six
hcvposit
sampl
viral
genom
copiesml
plasma
test
posit
hcvspecif
primer
set
three
hbvposit
sampl
copiespcr
test
posit
three
hbvspecif
primer
set
two
hbvposit
sampl
copiespcr
test
posit
two
three
hbvspecif
primer
set
import
note
none
primer
set
show
crossreact
virus
panel
clinic
sampl
test
studi
present
appli
realtim
pcr
array
approach
plate
platform
detect
group
target
viral
pathogen
contrast
taqman
pcr
commonli
use
viral
diagnost
platform
base
pcr
sybr
green
chemistri
support
simultan
detect
identif
differ
target
correspond
eight
differ
virus
pcr
base
sybr
green
stain
doubl
strand
dna
econom
afford
allow
detect
mutant
snp
within
amplicon
sequenc
strategi
primer
select
array
includ
sequenti
use
differ
bioinformat
program
identifi
highlyspecif
primer
set
maxim
variant
coverag
target
virus
work
univers
pcr
condit
experiment
select
process
use
panel
dna
rna
analyt
standard
allow
choos
two
four
sensit
specif
primer
set
target
viru
sensit
copi
number
per
pcr
reaction
intra
interassay
reproduc
quantif
character
primer
set
select
array
fdacber
analyt
plasma
panel
use
assess
detect
sensit
primer
set
select
work
array
hcv
rna
detect
low
genom
copiesml
human
plasma
one
three
two
two
primer
set
respect
similarli
wnv
rna
hbv
dna
detect
genom
copiesml
plasma
two
three
one
three
select
primer
set
respect
four
select
specif
primer
set
detect
group
subtyp
b
common
subtyp
america
western
europ
genom
copiesml
plasma
howev
array
abl
amplifi
subtyp
exclud
subtyp
f
group
one
primer
set
target
conserv
pol
region
genom
copiesml
plasma
addit
array
amplifi
group
n
isol
copiesml
anoth
primer
set
target
conserv
pol
region
select
specif
primer
set
array
fail
amplifi
group
isol
detect
limit
copiesml
plasma
comparison
limit
detect
lod
recent
improv
commerci
multiplex
nat
assay
broad
spectrum
group
isol
copiesml
lod
group
copiesml
thu
specif
primer
set
target
group
isol
well
subtyp
f
group
need
includ
array
increas
coverag
exist
subtypesgroup
crossreact
shown
specif
primer
type
hiv
test
medic
relev
level
virus
divers
panel
contain
differ
isol
three
natur
isol
collect
worldwid
present
us
food
drug
administr
fda
approv
pcrbase
nat
test
blood
donor
screen
offici
fda
world
health
organ
viral
panel
releas
two
virus
also
difficult
obtain
posit
blood
donor
sampl
unit
state
absenc
analyt
panel
clinic
sampl
test
vacv
specif
primer
cell
cultur
deriv
dna
dna
standard
minimum
detect
limit
specif
primer
set
estim
analyt
dna
standard
genom
copiespcr
reaction
rang
primer
includ
array
coverag
viral
variant
primer
target
virus
estim
silico
use
multipl
sequenc
align
perform
complet
genom
sequenc
avail
gen
bank
work
array
arrang
plate
format
subsequ
test
specif
potenti
crossreact
human
dna
target
virus
none
primer
set
select
particular
target
viru
array
produc
nonspecif
crossreact
toward
virus
compar
perform
array
also
evalu
test
clinic
specimen
unit
state
patient
popul
sampl
correctli
identifi
pcr
array
high
sensit
contain
hcv
hbv
found
combin
sever
primer
set
target
viru
array
allow
detect
differ
variant
viru
howev
make
absolut
quantif
uniform
dnarna
standard
challeng
quantif
assay
alway
possibl
genet
group
viral
isol
test
differ
assay
standard
one
reason
certain
case
commerci
assay
underestim
viral
load
copi
per
ml
nevertheless
rel
quantif
done
use
primer
set
select
array
absolut
quantif
perform
dnarna
standard
use
primer
target
conserv
genom
area
sever
commerci
qualit
multiplex
nat
assay
avail
market
simultan
target
three
import
bloodborn
viral
pathogen
hcv
hbv
one
recent
approv
us
fda
screen
blood
organ
donor
http
compar
lod
multiplex
nat
assay
result
work
pcr
array
sensit
test
import
virus
lod
hbv
geqml
procleix
ultrio
tigri
geqml
coba
lod
hcv
geqml
procleix
ultrio
tigri
geqml
coba
sensit
detect
hbv
hcv
pcr
array
appear
similar
rang
lod
subtyp
geqml
coba
array
compar
sensit
detect
viru
howev
describ
sensit
pcr
array
detect
broader
spectrum
differ
subtyp
isol
geqml
would
need
improv
lod
geqml
procleix
ultrio
tigri
geqml
coba
pcrcoupl
techniqu
develop
previous
highlysensit
pathogen
detect
could
reach
sensit
assay
genom
copi
per
pcr
reaction
exampl
bioactiv
amplif
probe
bap
util
nest
pcr
magnet
beadbas
hybrid
specif
probe
develop
detect
bovin
avian
virus
spite
exceed
sensit
assay
target
singl
viru
may
difficult
adapt
approach
method
meet
main
object
simultan
detect
multipl
target
viral
pathogen
array
use
univers
pcr
condit
import
note
array
develop
adapt
laboratori
comparison
experiment
obtain
tm
peak
rang
expect
specif
tm
peak
allow
rapid
identif
exclus
viral
pathogen
sampl
initi
studi
examin
suitabl
use
pcr
array
detect
group
target
virus
current
array
develop
util
five
previous
publish
origin
design
primer
set
howev
expand
larger
number
target
viru
target
sever
genom
area
increas
detect
sensit
target
viru
provid
intraassay
confirm
posit
signal
addit
new
viru
interest
ad
list
target
pathogen
effort
underway
test
util
realtim
pcr
array
use
sampl
divers
biolog
origin
pathogen
content
